Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed May 8, 2019 · 10-Q · 38 days after period end · 0001171843-19-003097
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Net Income | -$6.53M | -$6.08M | -$6.50M | -$6.55M |
| EPS Diluted | -$0.58 | -$0.34 | -$0.39 | -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 8, 2019 · 38 d after period end
